Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-048005
Filing Date
2026-04-27
Accepted
2026-04-27 16:01:24
Documents
1
Period of Report
2025-01-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1736
  Complete submission text file 0001213900-26-048005.txt   3249
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU China
Business Address 178 TAIDONG ROAD NORTH TAIZHOU China 8652386298290
China SXT Pharmaceuticals, Inc. (Issuer) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 178 TAIDONG RD NORTH TAIZHOU JIANGSU China 00000
Business Address
Chee Yong Lip (Reporting) CIK: 0002121823 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38773 | Film No.: 26900774